Biochemistry 2 Views 1 Answers
Avatar for Sourav Pan
Sourav PanApril 23, 2025

In an erythrocyte undergoing glycolysis, what would be the effect of a sudden increase in the concentration of a. ATP? b. AMP? c. fructose-1,6-bisphosphate? d. fructose-2,6-bisphosphate? e. citrate? f. glucose-6-phosphate?

In
an erythrocyte undergoing glycolysis, what would be the effect of a
sudden increase in the concentration of
a. ATP? b. AMP?
c. fructose-1,6-bisphosphate? d. fructose-2,6-bisphosphate?
e. citrate? f. glucose-6-phosphate?

Sourav Pan
Sourav PanApril 23, 2025

Answered

  • a. ATP

    • ATP acts as an allosteric inhibitor of phosphofructokinase-1 (PFK-1), a key regulatory enzyme in glycolysis.

    • An increase in ATP concentration signals sufficient energy availability, leading to decreased PFK-1 activity and a subsequent slowdown in glycolytic flux.

    • This negative feedback mechanism helps maintain energy homeostasis within the cell.

  • b. AMP

    • AMP serves as an allosteric activator of PFK-1.​

    • Elevated AMP levels indicate low cellular energy status, prompting an upregulation of glycolysis to generate more ATP.​

    • This positive feedback ensures rapid response to energy demands.​

  • c. Fructose-1,6-bisphosphate (F-1,6-BP)

    • F-1,6-BP is an intermediate in glycolysis that acts as an allosteric activator of pyruvate kinase (PK), enhancing the conversion of phosphoenolpyruvate to pyruvate.

    • An increase in F-1,6-BP concentration accelerates the latter stages of glycolysis, promoting efficient energy production.

  • d. Fructose-2,6-bisphosphate (F-2,6-BP)

    • F-2,6-BP is a potent allosteric activator of PFK-1 and an inhibitor of fructose-1,6-bisphosphatase.

    • Elevated levels of F-2,6-BP enhance glycolysis by increasing PFK-1 activity and simultaneously inhibit gluconeogenesis.

    • This dual regulation ensures a coordinated control of glucose metabolism.

  • e. Citrate

    • Citrate functions as an allosteric inhibitor of PFK-1.

    • An increase in citrate concentration reflects a high level of biosynthetic precursors, signaling to downregulate glycolysis.

    • This inhibition prevents excessive accumulation of metabolic intermediates.

  • f. Glucose-6-phosphate (G6P)

    • G6P acts as an allosteric inhibitor of hexokinase, the enzyme catalyzing the first step of glycolysis.

    • Elevated G6P levels indicate a bottleneck in downstream glycolytic steps, leading to feedback inhibition of glucose phosphorylation.

    • This regulation prevents unnecessary consumption of glucose when glycolytic flux is impeded.

Start Asking Questions

This site uses Akismet to reduce spam. Learn how your comment data is processed.

⚠️
  1. Click on your ad blocker icon in your browser's toolbar
  2. Select "Pause" or "Disable" for this website
  3. Refresh the page if it doesn't automatically reload